NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,446,000 | -3.6% | 37,744 | +1.5% | 1.38% | -14.2% |
Q1 2019 | $3,576,000 | -88.7% | 37,193 | +0.6% | 1.60% | +6.4% |
Q4 2018 | $31,732,000 | +885.8% | 36,980 | -2.7% | 1.51% | +12.1% |
Q3 2018 | $3,219,000 | +12.8% | 37,995 | +0.6% | 1.35% | +7.9% |
Q2 2018 | $2,854,000 | -2.6% | 37,783 | +4.2% | 1.25% | +0.1% |
Q1 2018 | $2,931,000 | -2.1% | 36,250 | +1.7% | 1.25% | +2.0% |
Q4 2017 | $2,993,000 | -0.7% | 35,644 | +1.5% | 1.22% | -3.3% |
Q3 2017 | $3,014,000 | +3.3% | 35,103 | +0.4% | 1.26% | -2.5% |
Q2 2017 | $2,917,000 | +6.3% | 34,946 | -5.4% | 1.30% | +5.0% |
Q1 2017 | $2,744,000 | +1.4% | 36,952 | -0.5% | 1.24% | -2.0% |
Q4 2016 | $2,707,000 | -8.5% | 37,150 | -0.9% | 1.26% | -8.4% |
Q3 2016 | $2,960,000 | -4.1% | 37,480 | +0.2% | 1.38% | -7.2% |
Q2 2016 | $3,086,000 | +16.0% | 37,404 | +1.9% | 1.48% | +0.3% |
Q1 2016 | $2,660,000 | – | 36,721 | – | 1.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |